GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (BOM:541304) » Definitions » Cash Flow for Dividends

Indo US Bio-Tech (BOM:541304) Cash Flow for Dividends : ₹0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Indo US Bio-Tech Cash Flow for Dividends?

Indo US Bio-Tech's cash flow for dividends for the three months ended in Dec. 2024 was ₹0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Indo US Bio-Tech's annual payment of dividends declined from Mar. 2022 (₹-1.5 Mil) to Mar. 2023 (₹0.0 Mil) but then stayed the same from Mar. 2023 (₹0.0 Mil) to Mar. 2024 (₹0.0 Mil).

Indo US Bio-Tech Cash Flow for Dividends Historical Data

The historical data trend for Indo US Bio-Tech's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Cash Flow for Dividends Chart

Indo US Bio-Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -1.52 - -

Indo US Bio-Tech Quarterly Data
Mar17 Oct17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indo US Bio-Tech Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo US Bio-Tech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (BOM:541304) » Definitions » Cash Flow for Dividends
Comparable Companies
BOM:524037 BOM:537291 BOM:543531 NSE:ANYA BOM:532935 BOM:539917 BOM:524480 NSE:NOVAAGRI BOM:590057 BOM:531862 CTVA TSX:NTR DSMD:IQCD SAU:2020 CF SZSE:000792 MOS OSL:YAR XTAE:ICL BOM:506395
Traded in Other Exchanges
INDOUS:India
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Website
https://www.indousagriseeds.com
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines